Tilray Inc (NASDAQ:TLRY - Get Free Report)'s stock price dropped 0.1% on Wednesday . The company traded as low as $0.91 and last traded at $0.94. Approximately 10,982,730 shares traded hands during mid-day trading, a decline of 77% from the average daily volume of 47,726,137 shares. The stock had previously closed at $0.94.
Analyst Ratings Changes
Separately, Canaccord Genuity Group raised their price target on shares of Tilray from $2.00 to $3.00 and gave the company a "buy" rating in a report on Monday, January 13th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $2.70.
Read Our Latest Stock Report on Tilray
Tilray Stock Down 1.1 %
The business's 50 day moving average is $1.20 and its 200 day moving average is $1.48. The company has a market capitalization of $874.65 million, a price-to-earnings ratio of -3.11 and a beta of 2.07. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.58 and a current ratio of 2.54.
Tilray (NASDAQ:TLRY - Get Free Report) last released its earnings results on Friday, January 10th. The company reported ($0.10) EPS for the quarter, missing analysts' consensus estimates of ($0.03) by ($0.07). The company had revenue of $210.90 million during the quarter, compared to analyst estimates of $216.34 million. Tilray had a negative return on equity of 4.40% and a negative net margin of 30.95%. The company's revenue was up 8.7% on a year-over-year basis. Sell-side analysts anticipate that Tilray Inc will post -0.2 earnings per share for the current year.
Institutional Trading of Tilray
Several institutional investors and hedge funds have recently bought and sold shares of TLRY. Ferguson Wellman Capital Management Inc. acquired a new stake in Tilray during the 3rd quarter valued at approximately $26,000. Lido Advisors LLC acquired a new stake in Tilray during the 4th quarter valued at approximately $28,000. Verdence Capital Advisors LLC acquired a new stake in Tilray during the 4th quarter valued at approximately $29,000. Dudley Capital Management LLC acquired a new stake in Tilray during the 4th quarter valued at approximately $29,000. Finally, Ameritas Advisory Services LLC acquired a new stake in Tilray during the 4th quarter valued at approximately $32,000. 9.35% of the stock is currently owned by institutional investors and hedge funds.
About Tilray
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Read More
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
